Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
8.56M
-
Shares change
-
+476K
-
Total reported value, excl. options
-
$68.7M
-
Value change
-
+$3.48M
-
Number of buys
-
20
-
Number of sells
-
-26
-
Price
-
$8.03
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q1 2022
60 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q1 2022.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.56M shares
of 22M outstanding shares and own 38.82% of the company stock.
Largest 10 shareholders include COWEN AND COMPANY, LLC (1.38M shares), Stonepine Capital Management, LLC (1.12M shares), WASATCH ADVISORS INC (1.09M shares), RTW INVESTMENTS, LP (990K shares), BlackRock Inc. (571K shares), VANGUARD GROUP INC (537K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (518K shares), PLATINUM INVESTMENT MANAGEMENT LTD (400K shares), PERKINS CAPITAL MANAGEMENT INC (201K shares), and Nantahala Capital Management, LLC (159K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.